The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand
about
Molecular basis for leukocyte integrin alpha(E)beta(7) adhesion to epithelial (E)-cadherinCrystal structure of two CD46 domains reveals an extended measles virus-binding surfaceInteraction of the poliovirus receptor with poliovirusStructures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation.Crystal structure of human junctional adhesion molecule 1: Implications for reovirus bindingCrystal structure of HAb18G/CD147: implications for immunoglobulin superfamily homophilic adhesionStructure of Reovirus σ1 in Complex with Its Receptor Junctional Adhesion Molecule-AEfalizumab binding to the LFA-1 L I domain blocks ICAM-1 binding via steric hindranceAdding the Third Dimension to Virus Life Cycles: Three-Dimensional Reconstruction of Icosahedral Viruses from Cryo-Electron MicrographsThe role of alpha and beta chains in ligand recognition by beta 7 integrinsOverview of protein folds in the immune system.The alphabet of intrinsic disorder: II. Various roles of glutamic acid in ordered and intrinsically disordered proteins.Mycoplasma suis infection results endothelial cell damage and activation: new insight into the cell tropism and pathogenicity of hemotrophic mycoplasma.Immunoglobulin superfamily virus receptors and the evolution of adaptive immunity.Inhibition of beta(2) integrin-mediated leukocyte cell adhesion by leucine-leucine-glycine motif-containing peptidesComplex structure of engineered modular domains defining molecular interaction between ICAM-1 and integrin LFA-1Mechanism of cooperative effects of rhinovirus and atopic sensitization on airway responsiveness.Rational design of anticytoadherence inhibitors for Plasmodium falciparum based on the crystal structure of human intercellular adhesion molecule 1.Coxsackievirus and adenovirus receptor amino-terminal immunoglobulin V-related domain binds adenovirus type 2 and fiber knob from adenovirus type 12Vascular endothelial growth factor signaling in hypoxia and inflammation.The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC.Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1.Engineering of single Ig superfamily domain of intercellular adhesion molecule 1 (ICAM-1) for native fold and function.Fitting background-selection predictions to levels of nucleotide variation and divergence along the human autosomes.Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium.Force spectroscopy of the leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction.Arbitrary protein-protein docking targets biologically relevant interfaces.Nontypeable Haemophilus influenzae adheres to intercellular adhesion molecule 1 (ICAM-1) on respiratory epithelial cells and upregulates ICAM-1 expression.Development of a homogeneous high-throughput screening assay for biological inhibitors of human rhinovirus infection.Novel Aeruginosin-865 from Nostoc sp. as a potent anti-inflammatory agent.Lymphocyte function-associated antigen-1 binding residues in intercellular adhesion molecule-2 (ICAM-2) and the integrin binding surface in the ICAM subfamily.Macrophage β2 integrin-mediated, HuR-dependent stabilization of angiogenic factor-encoding mRNAs in inflammatory angiogenesis.Immune modulating peptides for the treatment and suppression of multiple sclerosis.Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures.Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancerCelecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1Domain 1 of mucosal addressin cell adhesion molecule has an I1-set fold and a flexible integrin-binding loopThe effects of a small dose of dexamethasone on cell adhesion molecules during laparoscopic cholecystectomy.NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding.Prophylactic and therapeutic suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
P2860
Q24645674-4ACB72C4-3247-4B81-A5EC-B6860F3CB06DQ27618470-10812659-7E1E-43AE-A998-706577589A40Q27620834-34E19D6E-BE75-4D32-BAFD-DFAD0D91815EQ27640304-6C40A78A-6EEA-4B83-AFC7-37806C512EBCQ27640992-B2C51005-F864-4AF1-8471-E036FD90270BQ27650414-F3D823F1-DE9E-4746-AD91-DF2ACD1B6FE0Q27653146-A182EA92-ECE7-454A-B723-89245AE2459FQ27654007-8CD947F0-593E-4B02-91AA-57AEDAD9D51AQ27702159-ED69D997-D854-4B1B-9E83-D717DC7DAA52Q28145681-32EE964A-3965-40E4-A91B-A405E75AD5DCQ30369011-087262DA-56A8-4C06-BEFB-5BA186F873B3Q30402098-F08205F3-104A-4A84-AC81-992391FAECFAQ30536157-530892EF-A361-4BC0-B801-0C313C0F1FAAQ30944315-03D1C3BE-7057-4B27-916C-1B25FD3CF7C1Q30990845-AB06C5D5-872C-4B37-A288-1F46E8D8B347Q31089736-3C09EE77-8E7A-4E45-B106-6ED56BB19099Q31833973-13B2F734-CF8E-42BB-ABAD-09C93DE9101FQ33232476-15F55D76-F3BC-4113-A65D-8C50ED99058AQ33641414-DA8C3CDC-C012-4367-A0BA-28178ABCEB6FQ33721685-14E39935-9EAB-4443-858B-DC6F9AF089E5Q33819243-2AA58F9F-8CC0-4E10-A68E-646BF3690D38Q33850847-1021D6B2-23CF-4850-9F4B-FE72981A1B77Q33855145-9E43C427-AC11-44C6-B946-6A7FDD8C45FBQ33942576-375F6E40-C433-4E98-B287-70FEC267E0ACQ34064665-F9C34546-E966-41B6-BC33-987C8C323CF0Q34178974-C28E6C71-FE4E-4AFE-BDFA-7939BE53BB2FQ34257699-984DE73D-70CE-4F5D-A3B8-B5C55F3ADF14Q34334308-F08B4345-0E19-4F43-A0C7-0FB971A8C783Q34498975-33593968-117A-4C1C-8869-621F864E2DF3Q35016667-C11B562A-0AFE-44F6-9ED5-DEE9E67D06AAQ35064681-521835C3-C3BB-4734-B923-67CE730906B3Q35952080-243DB9A8-8F75-48CE-84A7-FBE471250495Q36151968-AF5BC4E3-B8CA-48CE-B883-7115D624D3FEQ36255960-341D1A78-799F-4925-B802-CFCFD277D82AQ36329068-54B67404-C66B-4867-BBE5-1ED082356C61Q36629600-6E9906AE-5A1E-4DEF-BFF8-AD04B5926F59Q36647282-FC5A8C74-482D-4F45-A21D-E62867B62A4BQ36649150-D87BD94A-1462-4D1C-8E2F-678383A47BAFQ36967455-58C10D0D-E714-42DB-ADBD-479B32FEDC30Q37002699-ED46DABB-4BB4-40B8-A400-12E4ABC4E52C
P2860
The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The structure of the two amino ...... nd as an LFA-1 integrin ligand
@ast
The structure of the two amino ...... nd as an LFA-1 integrin ligand
@en
The structure of the two amino ...... nd as an LFA-1 integrin ligand
@nl
type
label
The structure of the two amino ...... nd as an LFA-1 integrin ligand
@ast
The structure of the two amino ...... nd as an LFA-1 integrin ligand
@en
The structure of the two amino ...... nd as an LFA-1 integrin ligand
@nl
prefLabel
The structure of the two amino ...... nd as an LFA-1 integrin ligand
@ast
The structure of the two amino ...... nd as an LFA-1 integrin ligand
@en
The structure of the two amino ...... nd as an LFA-1 integrin ligand
@nl
P2093
P2860
P356
P1476
The structure of the two amino ...... nd as an LFA-1 integrin ligand
@en
P2093
P2860
P304
P356
10.1073/PNAS.95.8.4140
P407
P577
1998-04-14T00:00:00Z